We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use ÌìÃÀÓ°Ôº, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Letter templates to confirm a parent or carer has declined newborn blood spot screening.
Voluntary, community and social enterprise organisations (VCSE) can apply for funding to run schemes to help people access health services in the community.
Form for laboratories that wish to report newly identified acute or chronic hepatitis B infections on paper to PHE Colindale.
Public health and outbreak investigation.
Use this form to record and submit data to the Sloane Project.
Use this form for SARS-CoV-2 to request sample referrals from your regional public health unit.
Request form P4 to accompany Zika (no current symptoms) samples sent to the Rare and Imported Pathogens Laboratory.
Chlamydia trachomatis antibiotic resistance enhanced surveillance for male and female patients.
Form (B5) for Chlamydia trachomatis culture confirmation from patients with persistent infection.
For reporting mandatory surveillance of Clostridioides difficile infection to Public Health England.
Laboratories can use these templates to notify relevant clinicians of a presumed positive blood spot screening result for cystic fibrosis (CF).
Expressions of interest for a project which aims to improve people’s mental health through green social prescribing.
This template is used to notify GPs of a suspected positive newborn blood spot screening result of congenital hypothyroidism (CHT).
Laboratories can use this form when requesting a repeat immunoreactive trypsinogen (IRT) test if a first blood spot test is inconclusive for cystic fibrosis (CF).
Laboratories can use this template to notify a GP of a child's blood spot screening result of possible carrier of the cystic fibrosis (CF) gene.
Mycobacterium bovis questionnaire for doctors to use with patients. It asks about exposure to infected animals and animal products.
This tool provides local level estimates of hepatitis C disease burden.
Laboratories can use this template to notify a GP or child health records department (CHRD) that a child's blood spot screen for cystic fibrosis (CF) is not complete.
Healthcare professionals should complete this form for children whose screening result is presumed positive when giving results.
Submit data on women who are already known to the Sloane Project when they have been diagnosed with a further breast cancer, regional or distant event.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve ÌìÃÀÓ°Ôº, we’d like to know more about your visit today. .